These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22708516)

  • 1. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells.
    Gu Z; Gao S; Zhang F; Wang Z; Ma W; Davis RE; Wang Z
    Biochem J; 2012 Sep; 446(2):235-41. PubMed ID: 22708516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
    Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
    Zhang S; Ma Y; Hu X; Zheng Y; Chen X
    J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation.
    Sheng X; Wang Z
    BMC Cancer; 2016 Aug; 16():567. PubMed ID: 27480244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells.
    Zakrzewicz D; Didiasova M; Krüger M; Giaimo BD; Borggrefe T; Mieth M; Hocke AC; Zakrzewicz A; Schaefer L; Preissner KT; Wygrecka M
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1816-1827. PubMed ID: 29501774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.
    Zheng Y; Lu J; Hu X; Hu X; Gao X; Zhou J
    Technol Cancer Res Treat; 2023; 22():15330338231161139. PubMed ID: 36927233
    [No Abstract]   [Full Text] [Related]  

  • 9. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
    Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
    Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
    Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
    J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT5 activates KLF5 by methylation to facilitate lung cancer.
    Zhou H; Chang J; Zhang J; Zheng H; Miao X; Mo H; Sun J; Jia Q; Qi G
    J Cell Mol Med; 2024 Mar; 28(5):e17856. PubMed ID: 37461162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.
    Sheng X; Bowen N; Wang Z
    Mol Cancer; 2016 Mar; 15():25. PubMed ID: 26988096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors.
    Shilo K; Wu X; Sharma S; Welliver M; Duan W; Villalona-Calero M; Fukuoka J; Sif S; Baiocchi R; Hitchcock CL; Zhao W; Otterson GA
    Diagn Pathol; 2013 Dec; 8():201. PubMed ID: 24326178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells.
    Bajbouj K; Ramakrishnan RK; Saber-Ayad M; Omar HA; Saheb Sharif-Askari N; Shafarin J; Elmoselhi AB; Ihmaid A; AlHaj Ali S; Alalool A; Abdullah R; Hamid Q
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
    Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
    Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
    Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
    Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
    Yan F; Alinari L; Lustberg ME; Martin LK; Cordero-Nieves HM; Banasavadi-Siddegowda Y; Virk S; Barnholtz-Sloan J; Bell EH; Wojton J; Jacob NK; Chakravarti A; Nowicki MO; Wu X; Lapalombella R; Datta J; Yu B; Gordon K; Haseley A; Patton JT; Smith PL; Ryu J; Zhang X; Mo X; Marcucci G; Nuovo G; Kwon CH; Byrd JC; Chiocca EA; Li C; Sif S; Jacob S; Lawler S; Kaur B; Baiocchi RA
    Cancer Res; 2014 Mar; 74(6):1752-65. PubMed ID: 24453002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.
    Wei TY; Juan CC; Hisa JY; Su LJ; Lee YC; Chou HY; Chen JM; Wu YC; Chiu SC; Hsu CP; Liu KL; Yu CT
    Cancer Sci; 2012 Sep; 103(9):1640-50. PubMed ID: 22726390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 20. PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer.
    Huang J; Zheng Y; Zheng X; Qian B; Yin Q; Lu J; Lei H
    Cell Transplant; 2021; 30():9636897211001772. PubMed ID: 33829865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.